儿童一级亲属临床筛查肥厚型心肌病的检出率
该研究分析了1994至2017年间因一级亲属确诊肥厚型心肌病(HCM)而接受家族筛查的1198名儿童(≤18岁),中位随访3.5年。结果显示,基线时32人符合诊断标准,随访期间另有25人发展为HCM,诊断中位年龄10岁,72%在≤12岁。结论认为近5%的儿童一级亲属在首次或后续评估中符合HCM诊断标准,且多数为青春期前儿童,建议临床筛查应更早开始。
要点
- 儿童一级亲属筛查中近5%在首次或后续评估中符合HCM诊断标准。
- 诊断中位年龄10岁,72%在≤12岁,提示筛查应早于现行指南推荐的10岁。
- 有童年HCM家族史者诊断比例更高(56% vs 23%,P<0.001)。
核心结论
- 近5%的儿童一级亲属在首次或后续评估中符合HCM诊断标准,多数为青春期前儿童。
- 在受筛查家族中,8%的家庭有儿童一级亲属确诊HCM。
- 儿童期家族性HCM表型多样且可包括严重疾病,提示临床筛查应更早开始。
研究设计与样本
- 回顾性收集1994至2017年间因一级亲属确诊HCM而转诊接受家族筛查的儿童临床数据。
- 共纳入1198名连续儿童(≤18岁),来自594个家庭,接受系列评估(中位随访3.5年,四分位距1.2-7年)。
主要发现
- 基线时32人符合诊断标准(中位最大左心室壁厚度13 mm,四分位距8-21 mm),随访期间新增25例HCM。
- 诊断中位年龄10岁(四分位距4-13岁),44例(72%)≤12岁;末次随访中位年龄14岁(四分位距9.5-18.2岁)。
- 确诊HCM的患者中有童年HCM家族史者比例更高(32例中56% vs 257例中23%,P<0.001)。
- 18例(32%)因症状开始药物治疗;2例(4%)接受室间隔心肌切除术;14例(25%)植入ICD;1例接受心脏移植;2例心脏骤停复苏成功;1例死于脑血管意外。
关键数值与推荐
- 基线诊断标准依据原文未具体说明。
- 确诊HCM患者的中位最大左心室壁厚度为13 mm(四分位距8-21 mm)。
临床怎么用
- 对HCM患者的一级亲属儿童应进行临床筛查,且考虑在10岁前开始。
- 筛查应包括系列评估,因部分儿童在随访期间才发展为HCM。
- 有童年HCM家族史的儿童一级亲属筛查阳性率更高,应重点关注。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a heritable myocardial disease with age-related penetrance. Current guidelines recommend clinical screening of relatives beginning at 10 years of age, but the clinical value of this approach has not been systematically evaluated. METHODS: Anonymized clinical data were collected from children referred for family screening between 1994 and 2017 after diagnosis of HCM in a first-degree relative. RESULTS: Of 1198 consecutive children (≤18 years of age) from 594 families who underwent serial evaluation (median, 3.5 years; interquartile range, 1.2-7), 32 individuals met diagnostic criteria at baseline (median maximal left ventricular wall thickness, 13 mm; interquartile range, 8-21 mm), and 25 additional patients developed HCM during follow-up. Median age at diagnosis was 10 years (interquartile range, 4-13 years); 44 (72%) were ≤12 years of age. Median age of affected patients at the last follow-up was 14 years (interquartile range, 9.5-18.2 years). A family history of childhood HCM was more common in those patients diagnosed with HCM (n=32 [56%] versus n=257 [23%]; P<0.001). Eighteen patients (32%) were started on medication for symptoms; 2 (4%) underwent a septal myectomy; 14 (25%) received an implantable cardioverter-defibrillator; 1 underwent cardiac transplantation; 2 had a resuscitated cardiac arrest; and 1 died after a cerebrovascular accident. CONCLUSIONS: Almost 5% of first-degree child relatives undergoing screening meet diagnostic criteria for HCM at first or subsequent evaluations, with the majority presenting as preadolescents; a diagnosis in a child first-degree relative is made in 8% of families screened. The phenotype of familial HCM in childhood is varied and includes severe disease, suggesting that clinical screening should begin at a younger age.
引用
- Norrish G, Jager J, Field E, et al. Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives. Circulation. 2019. PMID: 31006259. doi:10.1161/CIRCULATIONAHA.118.038846
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。